GSK relaxing IP approach in poorer countries

On a conference call Thursday, CEO Andrew Witty said GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) is taking steps to align its patent filing and enforcement policies with various nations' levels of "economic

Read the full 309 word article

User Sign In